Loading...
CeriBell, Inc.
CBLL•NASDAQ
Healthcare
Medical - Devices
$14.96
$-0.17(-1.12%)
CeriBell, Inc. (CBLL) Financial Performance & Income Statement Overview
Review CeriBell, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
44.71%
↑ 44.71%
Operating Income Growth
-32.18%
↓ 32.18%
Net Income Growth
-37.30%
↓ 37.30%
Operating Cash Flow Growth
-20.18%
↓ 20.18%
Operating Margin
-63.98%
↓ 63.98%
Gross Margin
87.24%
↑ 87.24%
Net Profit Margin
-62.61%
↓ 62.61%
ROE
-163.62%
↓ 163.62%
ROIC
-22.55%
↓ 22.55%
CeriBell, Inc. (CBLL) Income Statement & Financial Overview
Review CeriBell, Inc.'s (CBLL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18.53M | $17.20M | $14.86M | $14.86M |
| Cost of Revenue | $2.30M | $2.18M | $2.11M | $2.11M |
| Gross Profit | $16.24M | $15.01M | $12.75M | $12.75M |
| Gross Profit Ratio | $0.88 | $0.87 | $0.86 | $0.86 |
| R&D Expenses | $3.91M | $3.40M | $3.13M | $3.13M |
| SG&A Expenses | $25.21M | $21.55M | $18.07M | $18.07M |
| Operating Expenses | $29.12M | $24.95M | $21.19M | $21.19M |
| Total Costs & Expenses | $31.42M | $27.13M | $23.30M | $23.30M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $499000.00 | $530000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $364000.00 | $243000.00 | $267000.00 | $267000.00 |
| EBITDA | -$11.71M | -$9.64M | -$8.18M | -$8.18M |
| EBITDA Ratio | -$0.63 | -$0.56 | -$0.55 | -$0.55 |
| Operating Income | -$12.88M | -$9.94M | -$8.44M | -$8.44M |
| Operating Income Ratio | -$0.70 | -$0.58 | -$0.57 | -$0.57 |
| Other Income/Expenses (Net) | $308000.00 | -$480000.00 | -$287000.00 | -$287000.00 |
| Income Before Tax | -$12.58M | -$10.42M | -$8.73M | -$8.73M |
| Income Before Tax Ratio | -$0.68 | -$0.61 | -$0.59 | -$0.59 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$12.58M | -$10.42M | -$8.73M | -$8.73M |
| Net Income Ratio | -$0.68 | -$0.61 | -$0.59 | -$0.59 |
| EPS | -$0.40 | -$0.31 | -$1.59 | -$1.59 |
| Diluted EPS | -$0.40 | -$0.31 | -$1.59 | -$1.59 |
| Weighted Avg Shares Outstanding | $31.21M | $34.02M | $5.51M | $5.51M |
| Weighted Avg Shares Outstanding (Diluted) | $31.21M | $34.02M | $5.51M | $5.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan